Gilead Sciences Inc (NAS:GILD)
$ 88.08 -0.68 (-0.77%) Market Cap: 109.66 Bil Enterprise Value: 131.08 Bil PE Ratio: 107.41 PB Ratio: 6.00 GF Score: 79/100

Gilead Sciences Inc at Jefferies Healthcare Conference (Virtual) Transcript

Jun 04, 2020 / 05:00PM GMT
Release Date Price: $77.54 (+4.22%)
Michael Jonathan Yee
Jefferies LLC, Research Division - Equity Analyst

Hey, everybody. Good afternoon. And welcome to a very exciting session here at the 2020 Jefferies Global Healthcare Conference. I know that you're really anticipating all of the great commentary out of Dan and Andy with us. I'm really happy to introduce the Chairman and CEO of Gilead, Dan O'Day, there on the right side; and then the Chief Financial Officer, Andy Dickinson, with the wonderful Golden Gate Bridge in the background.

Daniel P. O;Day
Gilead Sciences, Inc. - Chairman & CEO

' -

Hi, Mike.

Questions & Answers

Michael Jonathan Yee
Jefferies LLC, Research Division - Equity Analyst

Let me just start off by saying, Dan, it's great to see you guys, and Andy, everyone. Obviously, super proud and happy to see all of the developments, particularly with remdesivir this year. But I just wanted to take a step back for Dan and ask him sort of, we are in some crazy times. You obviously are still trying to manage a business

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot